Atrial septal defects (ASDs) represent the most common congenital heart defect diagnosed
in adulthood. Although considered a simple defect, challenges in optimal diagnostic and …

Atrial septal defects (ASDs) present a significant healthcare challenge, demanding accurate
and timely diagnosis and precise management to ensure optimal patient outcomes. Artificial …

Background Transcatheter (TC) atrial septal defect (ASD) closure has been the mainstay of
therapy for secundum-type ASDs for over 20 years. Aims This nationwide cohort evaluated …

Objectives: To evaluate safety, efficacy, and technical advantages of Amplatzer™ Trevisio™
intravascular delivery system (ATIDS) in percutaneous atrial septal defect (ASD) closure in …

Atrial septal defect is a common congenital heart disease, producing a left-to-right shunt in
the atrial septum; the current preferred treatment is transcatheter device closure. The aim is …

Objective The percutaneous closure of a single secundum atrial septal defect (ASD) under
transesophageal echocardiography guidance as an accepted alternative to the …

Atrial septal defect (ASD) is one of the most common congenital heart diseases (CHDs)
diagnosed in children. Symptoms in ASD may be absent, but palpitations and dyspnea in …

Percutaneous cardiac catheterisation is an essential modality in the diagnosis and
management of children with congenital cardiac disease. An increasing array of …

Background: Most existing studies measure atrial septal defect (ASD) outcomes based on
morbidity rates such as atrial arrhythmias and heart failure rather than the functional …

Background: Transcatheter atrial septal closures for secundum atrial septal defects (ASD)
have demonstrated favorable clinical outcomes. However, the impact of device implantation …